Molbio Diagnostics Limited - Enabling The World Implement Sophisticated Diagnostics Anytime, Anywhere.
Registered Corporate Office : Plot No. L-46, Phase II D, Verna Industrial Estate, Verna, Goa - 403 722, India
Tel.: +91-832-2783267/6724888
Branch Corporate Office : 1st floor, Tuberculosis Association of India Building Opp. New Parliament, 3 Red Cross Rd, New Delhi - 110001, India
Manufacturing Units
Site 1
Plot No. L-46, Phase II D, Verna Industrial Estate, Verna, Goa - 403 722, India
Tel.: +91-832-2783267
Site 3
MU2A – Type 1B, AMTZ Campus Near Pragati Maidan, VM Steel Projects Visakhapatnam, Andhra Pradesh – 530031, India
Site 5
L – 42, Phase II B, Verna Industrial Estate Verna, Goa – 403 722, India
Regional Offices (India)
North Zone
Delhi : 1st floor, Tuberculosis Association of India Building Opp. New Parliament, 3 Red Cross Rd New Delhi - 110001, India
Lucknow
106, Second Floor, 17/1, Metro Plaza, Indira Nagar Lucknow – 226015, India
West Zone
Mumbai : 612, Ecstasy Business Park, Near City of Joy, JSD Road Mulund West, Mumbai-400080, India
East Zone
Kolkata : Suite# 2B, 2nd Floor P-118 CIT Road, Scheme 6M Near Phoolbagan Metro station Kolkata – 700054
Patna : E-22, 2nd Floor, Krishna Apartment, North S.K. Puri Boring Road, Patna-800013, India
Guwahati : No II-207, Block-II, Sadashiva Apartment, Hatigaon Lashiminagar, Guwahati, Assam-781006, India
Raipur : R C Blood Bank, Canel Link Road, 1st floor, Pawan Vihar New Rajendra Nagar, Raipur, Chhattisgarh- 492001, India
South Zone
Bangalore : 2nd Floor, Golden Heights, 59th 'C' Cross, 59, 4th M Block Rajaji Nagar, Bengaluru, Karnataka - 560010, India
Vijaywada : 4D NO 29-28-79, Dasari Vari Street, Ground Floor Suraya Rao Peta, Vijayawada - 520008, India
Kochi : CC/28/2730 (57/543), Ponneth South Road, Kadavanthra, Ernakulam, Kerala - 682020, India
Chennai : No. 1/62 E, First Floor, Cross Street, Ravi Colony St. Thomas Mount, Chennai 600016, India
Molbio is an innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid, and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
Our flagship innovation, Truenat, is a novel POC polymerase chain reaction (PCR) platform that is battery-operated and can operate in resource-limited settings, facilitating decentralized diagnosis within an hour.
Operating in a high-entry-barrier, oligopolistic market, Truenat was the result of 13 years of rigorous research and development, culminating in certification and validation for TB testing by the Indian Council of Medical Research (ICMR).
Today, we are one of only two rapid molecular diagnostic platforms globally endorsed by the World Health Organization (WHO) for the initial detection of tuberculosis and rifampicin resistance.
Protected by patents in over 100 countries, Truenat enables diagnosis of a wide range of infectious and non-communicable diseases such as tuberculosis, COVID, Hepatitis B and C, Human immunodeficiency virus, Human Papillomavirus, etc.



Comments